12 May 2025, Mon

Media Mention: TA Associates invests in pharma products supplier Ideal Cures

Mint‘s coverage of the deal quotes Venture Intelligence data.

According to Venture Intelligence, this will be TA Associates’ third investment in the healthcare space in the last three years. It has previously backed Dr Lal Pathlabs Ltd, which went public in December 2015. It invested about $26 million in drug ingredients maker Shilpa Medicare in January this year.

Venture Intelligence is India’s longest serving provider of data and analysis on Private Company Financials, Transactions (private equity, venture capital and M&A) & their Valuations in India.

Loading

Leave a Reply

Your email address will not be published. Required fields are marked *